General characteristics of the study population and comparison of these characteristics between the two groups according to sleep apnea syndrome severity
Parameter
SAS patients
Group A (n = 22)
Group B (n = 49)
p-value*
Age, Me (25%; 75%)
69 (52; 71)
64 (55; 71)
61 (52; 70)
0.480
Sex ratio (Male/Female, %)
56/15 (3.73)
19/3 (6.33)
37/12 (3.08)
0.301
Hypertension (n, %)
33 (46.5)
7 (31.8)
26 (53.1)
0.097
Diabetes (n, %)
43 (60.6)
16 (72.7)
27 (55.1)
0.160
Dyslipidemia (n, %)
31 (43.7)
9 (40.9)
22 (44.9)
0.754
Smoking (n, %)
45 (63.4)
13 (59.1)
32 (65.3)
0.615
Chronic kidney disease (n, %)
14 (19.7)
4 (18.2)
10 (20.4)
0.827
Chronic obstructive pulmonary disease (n, %)
8 (11.3)
3 (13.6)
5 (10.2)
0.672
Body mass index (n, kg/m²)
29 ± 4
29 ± 4
28 ± 5
0.643
Heart failure with preserved ejection fraction (n, %)
26 (36.6)
7 (31.8)
19 (38.7)
0.574
Heart failure with mildly reduced ejection fraction (n, %)
10 (14.1)
3 (13.6)
7 (14.3)
0.942
Heart failure with reduced ejection fraction (n, %)
35 (49.3)
12 (54.5)
23 (46.9)
0.553
Significance level at p-value < 0.05; * comparison between Group A and Group B; Me (LQ; UQ): data presented as median with lower and upper quartiles
Declarations
Author contributions
S Antit: Conceptualization, Investigation, Methodology. FY: Investigation, Writing—original draft, Writing—review & editing. ML: Writing—original draft, Formal analysis. AB and S Abdellatif: Data curation. MRC: Supervision, Validation. LZ: Validation, Visualization. All authors read and approved the submitted version.
Conflicts of interest
The authors declare that they have no conflicts of interest.
Ethical approval
The study was approved by the Ethics Committee of the Internal Security Forces Hospital (Ethical approval number: 27/24).
Consent to participate
Informed consent to participate in the study was obtained from all participants.
Consent to publication
Not applicable.
Availability of data and materials
The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Young T, Peppard PE, Gottlieb DJ. Epidemiology of Obstructive Sleep Apnea: A Population Health Perspective.Am J Respir Crit Care Med. 2002;165:1217–39. [DOI] [PubMed]
Hedner J, Grote L, Bonsignore M, McNicholas W, Lavie P, Parati G, et al. The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories.Eur Respir J. 2011;38:635–42. [DOI] [PubMed]
Ibn Hadj Amor H, Touil I, Chebbi R, Bouchareb S, Bouchnak S, Brahem Y, et al. Assessment of right ventricular remodeling and dysfunction in obstructive sleep apnea syndrome: a prospective monocentric study.Sleep Breath. 2022;26:663–74. [DOI] [PubMed]
Chetan IM, Domokos Gergely B, Albu A, Tomoaia R, Todea DA. Understanding the role of echocardiography in patients with obstructive sleep apnea and right ventricular subclinical myocardial dysfunction—comparison with other conditions affecting RV deformation.Med Ultrason. 2021;23:213–9. [DOI] [PubMed]
Tugcu A, Yildirimtürk O, Tayyareci Y, Demiroglu C, Aytekin S. Evaluation of Subclinical Right Ventricular Dysfunction in Obstructive Sleep Apnea Patients Using Velocity Vector Imaging.Circ J. 2010;74:312–9. [DOI] [PubMed]
Cumpston E, Chen P. Sleep Apnea Syndrome.In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: http://www.ncbi.nlm.nih.gov/books/NBK564431/
Naughton MT. Epidemiology of central sleep apnoea in heart failure.Int J Cardiol. 2016;206:S4–7. [DOI] [PubMed]
Baguet J, Nadra M, Barone-Rochette G, Ormezzano O, Pierre H, Pépin J. Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea.Vasc Health Risk Manag. 2009;5:1063–73. [DOI] [PubMed] [PMC]
Hammerstingl C, Schueler R, Wiesen M, Momcilovic D, Pabst S, Nickenig G, et al. Impact of Untreated Obstructive Sleep Apnea on Left and Right Ventricular Myocardial Function and Effects of CPAP Therapy.PLoS One. 2013;8:e76352. [DOI] [PubMed] [PMC]
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al.; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.Eur Heart J. 2021;42:3599–726. [DOI] [PubMed]
Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.J Am Soc Echocardiogr. 2010;23:685–713. [DOI] [PubMed]
DiLorenzo MP, Bhatt SM, Mercer-Rosa L. How best to assess right ventricular function by echocardiography.Cardiol Young. 2015;25:1473–81. [DOI] [PubMed] [PMC]
Yumino D, Wang H, Floras JS, Newton GE, Mak S, Ruttanaumpawan P, et al. Prevalence and Physiological Predictors of Sleep Apnea in Patients With Heart Failure and Systolic Dysfunction.J Card Fail. 2009;15:279–85. [DOI] [PubMed]
Schulz R, Blau A, Börgel J, Duchna HW, Fietze I, Koper I, et al.; working group Kreislauf und Schlaf of the German Sleep Society (DGSM). Sleep apnoea in heart failure.Eur Respir J. 2007;29:1201–5. [DOI] [PubMed]
Kishan S, Rao MS, Ramachandran P, Devasia T, Samanth J. Prevalence and Patterns of Sleep-Disordered Breathing in Indian Heart Failure Population.Pulm Med. 2021;2021:9978906. [DOI] [PubMed] [PMC]
Paulino A, Damy T, Margarit L, Stoïca M, Deswarte G, Khouri L, et al. Prevalence of sleep-disordered breathing in a 316-patient French cohort of stable congestive heart failure: Prévalence des syndromes d’apnées du sommeil dans une cohorte française de 316 patients insuffisant cardiaques.Arch Cardiovasc Dis. 2009;102:169–75. [DOI] [PubMed]
Arzt M, Woehrle H, Oldenburg O, Graml A, Suling A, Erdmann E, et al.; SchlaHF Investigators. Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry.JACC Heart Fail. 2016;4:116–25. [DOI] [PubMed]
Salama S, Omar A, Ahmed Y, Abd El Sabour M, Seddik MI, Magdy D. Predictor factors of sleep-disordered breathing in heart failure.Egypt J Bronchol. 2017;11:36–43. [DOI]
Herrscher TE, Akre H, Øverland B, Sandvik L, Westheim AS. High Prevalence of Sleep Apnea in Heart Failure Outpatients: Even in Patients With Preserved Systolic Function.J Card Fail. 2011;17:420–5. [DOI] [PubMed]
Borrelli C, Gentile F, Sciarrone P, Mirizzi G, Vergaro G, Ghionzoli N, et al. Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction.Front Cardiovasc Med. 2019;6:125. [DOI] [PubMed] [PMC]
Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Töpfer V. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients.Eur J Heart Fail. 2007;9:251–7. [DOI] [PubMed]
Tadic M, Cuspidi C. Obstructive Sleep Apnea and Right Ventricular Remodeling: Do We Have All the Answers?J Clin Med. 2023;12:2421. [DOI] [PubMed] [PMC]
Romero-Corral A, Somers VK, Pellikka PA, Olson EJ, Bailey KR, Korinek J, et al. Decreased Right and Left Ventricular Myocardial Performance in Obstructive Sleep Apnea.Chest. 2007;132:1863–70. [DOI] [PubMed]
Dursunoglu N, Dursunoglu D, Ozkurt S, Gür S, Ozalp G, Evyapan F. Effects of CPAP on right ventricular myocardial performance index in obstructive sleep apnea patients without hypertension.Respir Res. 2006;7:22. [DOI] [PubMed] [PMC]
Akyol S, Cortuk M, Baykan AO, Kiraz K, Borekci A, Seker T, et al. Biventricular Myocardial Performance Is Impaired in Proportion to Severity of Obstructive Sleep Apnea.Tex Heart Inst J. 2016;43:119–25. [DOI] [PubMed] [PMC]
Altekin RE, Karakas MS, Yanikoglu A, Ozel D, Ozbudak O, Demir I, et al. Determination of right ventricular dysfunction using the speckle tracking echocardiography method in patients with obstructive sleep apnea.Cardiol J. 2012;19:130–9. [PubMed]
Shivalkar B, Van de Heyning C, Kerremans M, Rinkevich D, Verbraecken J, De Backer W, et al. Obstructive Sleep Apnea Syndrome: More Insights on Structural and Functional Cardiac Alterations, and the Effects of Treatment With Continuous Positive Airway Pressure.J Am Coll Cardiol. 2006;47:1433–9. [DOI] [PubMed]
